NYTimes: Kale? Juicing? Trouble Ahead

http://nyti.ms/1bBeSHk

“You’d be better off with chocolate and cola,” the dentist told me.

“ Talent hits a target no one else can hit; Genius hits a target no one else can see. ” – Arthur Schopenhauer

Happy and healthy new year!

Lets not just make empty promises to ourselves tonight. Let’s live every day of the new year like we are the most important person in the world! Make healthy choices. Train hard, smartly. Live fully.

Happy new year.

Scott

Stanford’s Distinct Training Regimen Redefines Strength – NYTimes.com

http://mobile.nytimes.com/2013/12/31/sports/ncaafootball/stanfords-distinct-training-regimen-redefines-strength.html?pagewanted=1&_r=0

“ Talent hits a target no one else can hit; Genius hits a target no one else can see. ” – Arthur Schopenhauer

NYTimes: For Fitness, Intensity Matters

http://nyti.ms/K21Psh

The lesson that seemed to emerge most persistently from the fitness-related studies published this year was that intensity matters, especially if you wish to complete your workout quickly.

“ Talent hits a target no one else can hit; Genius hits a target no one else can see. ” – Arthur Schopenhauer

NYTimes: Skip the Supplements

http://nyti.ms/1j5s8xA
Remember, if the label doesn’t include “USP CERTIFICATION”, don’t buy it or inject it! You literally have no idea what’s actually in the bottle.

Dietary supplements: mislabeled, contaminated and probably useless.

“ Talent hits a target no one else can hit; Genius hits a target no one else can see. ” – Arthur Schopenhauer

Breaking News: Nelson Mandela, South African Icon of Peaceful Resistance, Is Dead

A sad day.

“ Talent hits a target no one else can hit; Genius hits a target no one else can see. ” – Arthur Schopenhauer

Begin forwarded message:

From: nytdirect>
Date: December 5, 2013 at 4:57:27 PM EST
To: scott.salbo
Subject: Breaking News: Nelson Mandela, South African Icon of Peaceful Resistance, Is Dead

To ensure delivery to your inbox, please add nytdirect@nytimes.com to your address book.
The New York Times | BREAKING NEWS ALERT
NYTimes.com | Unsubscribe
BREAKING NEWS Thursday, December 5, 2013 4:52 PM EST
Nelson Mandela, South African Icon of Peaceful Resistance, Is Dead

Nelson Mandela, South Africa’s first black president and an enduring icon of the struggle against racial oppression, died on Thursday the government announced, leaving the nation without its moral center at a time of growing dissatisfaction with the country’s leaders.
Mr. Mandela spent 27 years in prison after being convicted of treason by the white minority government, only to forge a peaceful end to white rule by negotiating with his captors after his release in 1990. He led the African National Congress, long a banned liberation movement, to a resounding electoral victory in 1994, the first fully democratic election in the country’s history.
Mr. Mandela served just one term as South Africa’s president and had not made a public appearance since 2010, when the nation hosted the World Cup. But his decades in prison and his insistence on forgiveness over vengeance made him a potent symbol of the struggle to end his country’s brutally codified system of racial domination, and of the power of peaceful resolution in even the most intractable conflicts.
Years after he retreated from public life, his name still resonated as an emblem of his effort to transcend decades of racial division and create what South Africans called a Rainbow Nation.

READ MORE »

http://www.nytimes.com/2013/12/06/world/africa/nelson-mandela.html?emc=edit_na_20131205

ADVERTISEMENT
imp?s=62659&t=newsletter&sz=300x250&li=BreakingNews&m=E7696201354C37AEB8B3BEFEE7275171&p=2013.12.05.21.57.27
imp?s=62660&t=newsletter&sz=1x1&li=BreakingNews&m=E7696201354C37AEB8B3BEFEE7275171&p=2013.12.05.21.57.27 imp?s=62661&t=newsletter&sz=1x1&li=BreakingNews&m=E7696201354C37AEB8B3BEFEE7275171&p=2013.12.05.21.57.27
imp?s=2297&t=newsletter&sz=116x15&li=BreakingNews&m=E7696201354C37AEB8B3BEFEE7275171&p=2013.12.05.21.57.27 imp?s=2298&t=newsletter&sz=69x15&li=BreakingNews&m=E7696201354C37AEB8B3BEFEE7275171&p=2013.12.05.21.57.27
imp?s=62662&t=newsletter&sz=2x1&li=BreakingNews&m=E7696201354C37AEB8B3BEFEE7275171&p=2013.12.05.21.57.27 imp?s=62663&t=newsletter&sz=2x1&li=BreakingNews&m=E7696201354C37AEB8B3BEFEE7275171&p=2013.12.05.21.57.27 imp?s=62664&t=newsletter&sz=2x1&li=BreakingNews&m=E7696201354C37AEB8B3BEFEE7275171&p=2013.12.05.21.57.27 imp?s=62665&t=newsletter&sz=2x1&li=BreakingNews&m=E7696201354C37AEB8B3BEFEE7275171&p=2013.12.05.21.57.27 imp?s=62666&t=newsletter&sz=2x1&li=BreakingNews&m=E7696201354C37AEB8B3BEFEE7275171&p=2013.12.05.21.57.27 imp?s=62667&t=newsletter&sz=2x1&li=BreakingNews&m=E7696201354C37AEB8B3BEFEE7275171&p=2013.12.05.21.57.27 imp?s=62668&t=newsletter&sz=2x1&li=BreakingNews&m=E7696201354C37AEB8B3BEFEE7275171&p=2013.12.05.21.57.27 imp?s=62669&t=newsletter&sz=2x1&li=BreakingNews&m=E7696201354C37AEB8B3BEFEE7275171&p=2013.12.05.21.57.27 imp?s=62670&t=newsletter&sz=2x1&li=BreakingNews&m=E7696201354C37AEB8B3BEFEE7275171&p=2013.12.05.21.57.27 imp?s=62671&t=newsletter&sz=2x1&li=BreakingNews&m=E7696201354C37AEB8B3BEFEE7275171&p=2013.12.05.21.57.27 imp?s=62672&t=newsletter&sz=2x1&li=BreakingNews&m=E7696201354C37AEB8B3BEFEE7275171&p=2013.12.05.21.57.27 imp?s=62673&t=newsletter&sz=2x1&li=BreakingNews&m=E7696201354C37AEB8B3BEFEE7275171&p=2013.12.05.21.57.27

pixel.gif?r=9dbaad520ccf62ad66a806f22f1f3b4689e74e0c&s=scott.salbo@gmail.com&id=55374068&gender=0

FOLLOW US: Twitter @NYTimes | Facebook Facebook
For breaking news on your mobile device, go to m.nyt.com »
NYT Access The New York Times from anywhere with our suite of apps:
iPhone® | iPad® | Android | All

About This Email

This is an automated email. Please do not reply directly to this email.

You received this message because you signed up for NYTimes.com‘s breaking news alerts. As a member of the TRUSTe privacy program, we are committed to protecting your privacy.

Unsubscribe | Manage Subscriptions | Change Your Email | Privacy Policy | Contact

Copyright 2013 | The New York Times Company |NYTimes.com 620 Eighth Avenue New York, NY 10018

r7ihwOf5XePlpJ1w==&campaign_id=132&instance_id=34862&segment_id=53175&user_id=e7696201354c37aeb8b3befee7275171&regi_id=55374068

NYTimes: Experts Reshape Treatment Guide for Cholesterol

I’ve been arguing with my doctors for years that the cholesterol guidelines were either arbitrary or handwritten by the pharmaceutical industry to ensure as many people as possible were given prescriptions.

The relationship between cholesterol and heart disease is tenuous, and highly anecdotal, and I’ve watched the “acceptable” number continuously drop over the years, all while other criteria were constantly added to the mix of excuses to add more people to the prescription drug rolls. Now we’re told the number isn’t so important after all.

We need a truly independent FDA that funds it’s own health research and then commissions big pharma after the fact. Read on.

http://nyti.ms/17sUo88

The guidelines from the nation’s leading heart organizations will fundamentally reshape the use of cholesterol-lowering statin medicines now prescribed for a quarter of Americans over 40.

“ Talent hits a target no one else can hit; Genius hits a target no one else can see. ” – Arthur Schopenhauer